042520 Stock Chart & Stats
₩18600.00
₩560.00(3.10%)
―
--
Day’s Range― - ―
52-Week Range₩6,970.00 - ₩57,800.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)204.96K
Market Cap
₩255.23B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.88
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding14,261,367
10 Day Avg. Volume182,115
30 Day Avg. Volume204,959
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1,149
Revenue Forecast (FY)₩144.00B
042520 FAQ
What was Hans Biomed Corp’s price range in the past 12 months?
Hans Biomed Corp lowest stock price was ₩6970.00 and its highest was ₩57800.00 in the past 12 months.
What is Hans Biomed Corp’s market cap?
Hans Biomed Corp’s market cap is ₩255.23B.
When is Hans Biomed Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Hans Biomed Corp’s earnings last quarter?
Hans Biomed Corp released its earnings results on May 14, 2026. The company reported ₩277.989 earnings per share for the quarter, beating the consensus estimate of N/A by ₩277.989.
Is Hans Biomed Corp overvalued?
According to Wall Street analysts Hans Biomed Corp’s price is currently Undervalued.
Does Hans Biomed Corp pay dividends?
Hans Biomed Corp does not currently pay dividends.
What is Hans Biomed Corp’s EPS estimate?
Hans Biomed Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hans Biomed Corp have?
Hans Biomed Corp has 14,261,367 shares outstanding.
What happened to Hans Biomed Corp’s price movement after its last earnings report?
Hans Biomed Corp reported an EPS of ₩277.989 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 21.304%.
Which hedge fund is a major shareholder of Hans Biomed Corp?
Currently, no hedge funds are holding shares in KR:042520
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dentium Co., Ltd.
―
HUMEDIX Co.LTD.
―
EuBiologics Co., Ltd.
―
Curocell, Inc.
―
Nextbiomedical Co. Ltd.
―